Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit Dose NDC 50268-786-13 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

D-1133-2018

August 14, 2018

Class II

Product summary

Firm
AVKARE Inc.
Event
Event 80828
Status
Terminated
Classification
Class II
Quantity
1496 cartons (44,880 tablets)
Official record key
drug-enforcement:D-1133-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lots: 17718 Exp. 07/2018; 18700 Exp. 01/2019; 19133 Exp. 02/2019; 19532 Exp. 04/2019

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations